Related Articles
Use of CA15‑3 for screening breast cancer: An antibody‑lectin sandwich assay for detecting glycosylation of CA15‑3 in sera
Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients
DETECTION AND COMPARISON OF A 90-KD GLYCOPROTEIN TUMOR-ASSOCIATED ANTIGEN-SPECIFIC IMMUNE-COMPLEXES WITH CEA AND CA15-3 IN BREAST-CANCER
Binding of circulating anti-MUC1 antibody and serum MUC1 antigen in stage IV breast cancer
Salivary protein factors are elevated in breast cancer patients